Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Eris Lifesciences enters into term loan agreement with Citi Bank
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Subscribe To Our Newsletter & Stay Updated
